LONDON--(BUSINESS WIRE)--The global flow diversion aneurysm treatment market is poised to grow by USD 1.64 billion during 2020-2024 progressing at a CAGR of over 8 % during the forecast period.
The report on the global flow diversion aneurysm treatment market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the improvements in detection of UIAs.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis
The flow diversion aneurysm treatment market analysis includes the product segment and geographical landscapes. This study identifies the increasing R&D focus as one of the prime reasons driving the flow diversion aneurysm treatment market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The flow diversion aneurysm treatment market covers the following areas:
- Flow Diversion Aneurysm Treatment Market Sizing
- Flow Diversion Aneurysm Treatment Market Forecast
- Flow Diversion Aneurysm Treatment Market Industry Analysis
Companies Mentioned
- Acandis GmbH
- Boston Scientific Corp.
- Cardinal Health Inc.
- Cook Group Inc.
- Johnson & Johnson
- Medtronic Plc
- MicroPort Scientific Corp.
- phenox GmbH
- Stryker Corp.
- Terumo Corp.
Key Topics Covered:
Executive Summary
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 – 2024
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- FDS - Market size and forecast 2019-2024
- Intrasaccular flow disruption devices - Market size and forecast 2019-2024
- Market opportunity by Product
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Vendor landscape
- Landscape disruption
- Competitive scenario
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Acandis GmbH
- Boston Scientific Corp.
- Cardinal Health Inc.
- Cook Group Inc.
- Johnson & Johnson
- Medtronic Plc
- MicroPort Scientific Corp.
- phenox GmbH
- Stryker Corp.
- Terumo Corp.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
